The Bariatric Surgery Devices Market is set to exceed USD 2.2 billion by 2024; according to a new research report by Global Market Insights.
High demand for minimally invasive surgical procedures will significantly drive bariatric surgery devices market growth over the forecast period. Reduction in post-operative trauma and complications with use of minimally invasive surgical procedure is the major growth driver. Reduced hospital stays, and lesser healing time are other advantages of bariatric surgical devices. Such factors will favor considerable growth in the future.
Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/2735
Increasing government funding will spur demand for bariatric surgeries in upcoming years. For instance, National Institute of Diabetes and Digestive Kidney Diseases (NIDDK) provided about USD 1.3 million to Miriam Hospital in US for development of advanced technologies that support bariatric surgery. This will positively impact adoption of bariatric surgical procedures, thereby driving business growth during the forecast period.
Company profiled in this report based on Business overview, Financial data, Product landscape, Strategic outlook & SWOT analysis:
- Ethicon, Inc.
- Olympus Corporation of the Americas
- L. Gore & Associates
- CONMED Corporation
- Integra LifeSciences
- Apollo Endosurgery
- Cousin Biotech
- Aspire Bariatrics
- Grena Limited
- ReShape Lifesciences Inc.
- Mediflex Surgical Products
Minimally invasive surgical device segment accounted for largest revenue of USD 1,378.1 million in 2017. Patients with gastrointestinal diseases using minimally invasive techniques experience less pain, reduced costs of treatment, and recovery time. Improved design to provide maximum efficiency will favor segmental growth in the future.
Sleeve gastrectomy segment is expected to grow at 6.1% during the forecast timeframe. Segmental growth is attributable to lesser number of complications and higher efficacy. According to American Society for Metabolic and Bariatric Surgery (ASMBS), about 59% of bariatric surgeries performed were sleeve gastrectomy. Increasing patient preference and affordability of sleeve gastrectomy will favor segmental growth over forecast timeframe.
Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/2735
U.S. bariatric surgery devices market will grow at 5.6%, owing to high pervasiveness of obesity. According to National Institute of Diabetes and Digestive Kidney Diseases (NIDDK), 1 in 3 adults in U.S. suffer from obesity. High prevalence of obesity coupled with high disposable income and increasing government expenditure on healthcare will further lead to business growth in the future.
Japan bariatric surgery devices market accounted for revenue size of USD 92.6 million in 2017 owing to rising number of bariatric surgical procedures including sleeve gastrectomy. According to NCBI 2015 report, more than 70% sleeve gastrectomy surgical procedures were performed in Japan. In addition, sedentary lifestyle as well as unhealthy diet habits are also contributing factors for obesity that will foster industry growth in upcoming years.